No attachments available.
Gene Therapy Resource Program (GTRP)
Contact and place of performance
Rashida S. Ferebee
Not specified
The NHLBI requires the Gene Therapy Resource Program (GTRP) support translational gene therapy research by providing resources and services from three core laboratories: 1.) Pharmacology and Toxicology Core Laboratory, 2.) Preclinical Vector Core Laboratory, 3.) Clinical Coordinating Center (CCC), which is not required to have any laboratory capabilities.
The National Heart, Lung, and Blood Institute (NHLBI) has issued an award notice for the Gene Therapy Resource Program (GTRP) under solicitation number HHSN26818HV00005R. This program supports translational gene therapy research through the provision of resources and services managed by three core entities. These include a Pharmacology and Toxicology Core Laboratory, a Preclinical Vector Core Laboratory, and a Clinical Coordinating Center, the latter of which functions without a requirement for laboratory capabilities.
The primary classification for this requirement is NAICS 541714 for Research and Development in Biotechnology (except Nanobiotechnology) and PSC code A. This award notice was published on December 21, 2018, by the Department of Health and Human Services. Rashida S. Ferebee is identified as the point of contact for this action. No set-aside designations or specific performance locations were detailed in the notice metadata.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.